Today: 7 April 2026
Subscribe

AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti shares closed up 6% at $121.12 Monday after gold surged on U.S. tariff headlines, then slipped Tuesday as bullion prices fell over 1%. The company corrected a dividend date error, confirming March 13, 2026, as the record date. AngloGold recently reported a near tripling in annual profit and new reserves at its Nevada project.
24 February 2026
···
Equinox Gold stock swings as dividend and buyback plans collide with softer gold prices

Equinox Gold stock swings as dividend and buyback plans collide with softer gold prices

Equinox Gold shares closed up 6.25% in Toronto on Monday after the company declared its first quarterly dividend and applied for a share buyback. U.S.-listed shares last traded at $17.85, up about 6% after hours. The company reported net debt of $75 million at Jan. 31 after reducing debt by $1.1 billion since mid-2025. Gold prices fell over 1% on Tuesday, posing a near-term challenge for miners.
24 February 2026
···
NESR stock rises premarket as National Energy Services Reunited pushes into fresh 52-week highs

NESR stock rises premarket as National Energy Services Reunited pushes into fresh 52-week highs

NESR shares rose 2.5% to $26.70 in premarket trading Tuesday after a 6.8% jump the prior session, nearing the top of their 52-week range. The company reported Q4 revenue of $398.3 million and adjusted EPS of $0.32, beating estimates, but net income fell to $7.8 million due to impairment and restructuring charges. Management is scheduled to meet investors at conferences in Houston and Las Vegas.
24 February 2026
··
Dianthus Therapeutics (DNTH) stock rises ahead of TD Cowen conference; what investors watch next

Dianthus Therapeutics (DNTH) stock rises ahead of TD Cowen conference; what investors watch next

Dianthus Therapeutics shares rose 6.3% to $52.68 Monday ahead of CEO Marino Garcia’s scheduled fireside chat at TD Cowen’s health care conference on March 3. Volume reached about 944,000 shares. Investors are watching for updates on the company’s autoimmune pipeline and trial timelines. The event will be webcast and include one-on-one investor meetings.
24 February 2026
··
Bloom Energy stock slips before the open after 9% rally — here’s what traders are watching

Bloom Energy stock slips before the open after 9% rally — here’s what traders are watching

Bloom Energy shares fell 1.6% to $157.80 in premarket trading Tuesday after an 8.6% surge the previous session. Director Jeffrey Immelt disclosed gifting 4,000 shares in a late Monday SEC filing. Tariff uncertainty and Nvidia’s results this week are influencing AI-linked stock moves. Bloom’s 2026 revenue forecast stands at up to $3.3 billion, with a reported backlog of about $20 billion.
24 February 2026
··
Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech shares slipped 0.2% to $19.72 in premarket trading Tuesday after a 9% jump the previous session, following news of Gilead’s $7.8 billion deal to buy Arcellx. The acquisition put focus on rival CAR-T therapies, with Arcellx’s anito-cel under FDA review and analysts citing possible safety advantages over Legend’s Carvykti, which generated $1.9 billion in 2025 sales.
24 February 2026
·
Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics shares fell 0.5% to $34.30 in premarket trading Tuesday after an 11.1% surge Monday, as investors reacted to new obesity drug trial data from Novo Nordisk. Novo’s CagriSema showed less weight loss than Eli Lilly’s rival drug, shaking the sector. Viking plans to advance its oral obesity drug VK2735 into late-stage trials in Q3. Investors await updates at upcoming healthcare conferences in March and April.
24 February 2026
··
Bank of America stock steadies premarket after Monday’s drop as tariff jitters rattle banks

Bank of America stock steadies premarket after Monday’s drop as tariff jitters rattle banks

Bank of America shares were little changed in premarket trading Tuesday after closing down 3.75% amid a broad selloff in bank stocks. The KBW Regional Banking Index dropped 4.26% Monday as Treasury yields swung and investors weighed tariff headlines. JPMorgan, Wells Fargo, and Morgan Stanley each fell about 4%. U.S. stock futures edged higher early Tuesday ahead of key earnings and policy events.
24 February 2026
·······
Blue Owl stock price drops premarket after Deutsche Bank downgrade as private-credit jitters linger

Blue Owl stock price drops premarket after Deutsche Bank downgrade as private-credit jitters linger

Blue Owl Capital shares dropped 4.2% in premarket trading Tuesday after Deutsche Bank downgraded the stock to Hold and cut its price target to $10. The move follows rising investor concern over private-credit fund liquidity and exposure to software loans. Blue Owl has lost over 16% in five days amid headlines on fund withdrawals and a disputed financing issue tied to CoreWeave. Investors are watching for the March 2 dividend payment.
24 February 2026
·
Palantir stock price slides with software selloff; tariffs and Nvidia earnings set the next test

Palantir stock price slides with software selloff; tariffs and Nvidia earnings set the next test

Palantir shares fell 3.4% to $130.60 on Monday as investors sold off high-risk software stocks amid tariff uncertainty and renewed debate over AI disruption. U.S. stock indexes also declined, with software among the hardest hit. Traders are watching for Nvidia’s earnings report Wednesday, seen as the next major driver for AI-linked stocks. Futures edged higher early Tuesday, but markets remain volatile as tariff policy shifts.
24 February 2026
···
American Airlines stock slips before open as Northeast blizzard snarls flights and shelf filing hits tape

American Airlines stock slips before open as Northeast blizzard snarls flights and shelf filing hits tape

American Airlines shares fell 4.8% to $12.93 in premarket trading after a Northeast blizzard forced widespread flight cancellations. The company also filed a shelf registration late Monday, allowing for possible future sales of stock or debt. Operations resumed at Washington Reagan National and Philadelphia, with New York and Boston expected later Tuesday. Delta and United stocks also declined.
24 February 2026
···
Novo Nordisk stock slips again as CagriSema miss drives forecast cuts and puts next catalysts in focus

Novo Nordisk stock slips again as CagriSema miss drives forecast cuts and puts next catalysts in focus

Novo Nordisk shares fell 2.5% to 245.1 Danish crowns Tuesday after its CagriSema obesity drug failed to match Eli Lilly’s tirzepatide in a Phase 3 trial. Barclays cut its peak sales forecast for CagriSema to $2 billion from $12 billion. Novo also reported mid-stage China trial results for its “triple G” obesity drug UBT251, showing up to 19.7% weight loss after 24 weeks.
24 February 2026
··
Nvidia stock steadies in premarket as earnings loom and AI spend faces scrutiny

Nvidia stock steadies in premarket as earnings loom and AI spend faces scrutiny

Nvidia shares traded at $191.55, up 0.9%, ahead of quarterly results due Wednesday after the bell. Options markets signal a possible 6% swing in either direction, reflecting investor focus on AI demand, supply constraints, and China sales. Wall Street expects revenue to jump over 68% to $66.16 billion. The company will release results at 4:20 p.m. ET, with a conference call at 5 p.m.
24 February 2026
····
1 … 103 104 105 106 107 … 1,844

Stock Market Today

  • SoundHound AI Shares Slip 1.2% Amid Mixed Analyst Ratings
    April 6, 2026, 8:38 PM EDT. SoundHound AI (NASDAQ:SOUN) saw its stock price drop 1.2% to $6.70 on Monday, with trading volume down 46% from average. The voice AI company's shares traded as low as $6.66 amid mixed Wall Street responses. Cantor Fitzgerald upgraded the stock to "overweight" and raised the price target to $15. Meanwhile, HC Wainwright lowered its target from $26 to $20, and Piper Sandler cut theirs from $11 to $9. SoundHound AI develops speech recognition and natural language technologies for businesses, making its stock a barometer for trends in AI and enterprise software. Investors remain cautious as the firm faces industry challenges against opportunities in a competitive market.
Go toTop